xxxxxSTEM
xxxxxSTEM Articles
StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to $100 million in securities sales via any combination of stock, debt, preferred...
Published:
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China,...
Published:
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates and...
Published:
Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would note that many of the largest market...
Published:
Despite not knowing whom the ultimate winner of the 2008 Presidential election will be, it looks like stem cells may be one of the real bright spots as far as which area in biotech will be open for...
Published:
Last Updated:
Below are some of the top issues affecting biotech shares today: AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4%...
Published:
Stock Tickers: STEM, GERN, ASTM Senator Obama has issued a statement regarding President Bush’s veto of the Embryonic Stem Cell Bill: Senator Obama noted: "By vetoing funding for stem cell...
Published: